D.E. Shaw & Co
RCEL icon

D.E. Shaw & Co’s Avita Medical RCEL Stock Holding History

D.E. Shaw & Co’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,971
Closed -$328K – 4861
2025
Q2 		$328K Sell
61,971
-9,737
-14% -$70.8K ﹤0.01% 3826
2025
Q1 		$584K Buy
71,708
+5,160
+8% +$48.2K ﹤0.01% 3413
2024
Q4 		$852K Sell
66,548
-548
-0.8% -$6.46K ﹤0.01% 3296
2024
Q3 		$719K Sell
67,096
-17,733
-21% -$167K ﹤0.01% 3494
2024
Q2 		$672K Buy
84,829
+36,700
+76% +$349K ﹤0.01% 3438
2024
Q1 		$772K Sell
48,129
-2,427
-5% -$39.3K ﹤0.01% 3255
2023
Q4 		$694K Sell
50,556
-3,060
-6% -$35.1K ﹤0.01% 3365
2023
Q3 		$783K Sell
53,616
-25,739
-32% -$436K ﹤0.01% 3210
2023
Q2 		$1.35M Sell
79,355
-41,344
-34% -$607K ﹤0.01% 2905
2023
Q1 		$1.69M Buy
120,699
+90,987
+306% +$968K ﹤0.01% 2819
2022
Q4 		$196K Buy
29,712
+9,871
+50% +$59.2K ﹤0.01% 4256
2022
Q3 		$105K Sell
19,841
-317
-2% -$1.96K ﹤0.01% 4592
2022
Q2 		$96K Sell
20,158
-9,957
-33% -$61.5K ﹤0.01% 4739
2022
Q1 		$255K Buy
+30,115
New +$278K ﹤0.01% 4736
2021
Q4 		– Sell
-12,966
Closed -$230K – 5655
2021
Q3 		$230K Buy
12,966
+2,969
+30% +$56K ﹤0.01% 4503
2021
Q2 		$205K Buy
+9,997
New +$197K ﹤0.01% 4444

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

D.E. Shaw & Co's RCEL Position: Q3 2025 in Review

D.E. Shaw & Co sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 61,971 shares — an estimated $328K sold.

D.E. Shaw & Co first reported a position in RCEL in Q2 2021 and held it in 16 quarters. The position peaked at $1.69M in Q1 2023. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • D.E. Shaw & Co reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 61,971 Avita Medical shares in Q3 2025, an estimated $328K.
  • D.E. Shaw & Co first reported a position in Avita Medical in Q2 2021 and held it in 16 quarters.
  • D.E. Shaw & Co's Avita Medical position peaked at $1.69M in Q1 2023.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.